Mutual Funds that own BTG PLC
Invesco Perpetual UK Invt. Ser. - High Income
37,983,371
9.81%
-2,552,799
2.17%
03/29/2018
CF Woodford Equity Income
18,293,690
4.73%
0
1.65%
07/31/2018
Invesco Perpetual UK 2 Invt. Series - Income Fund
16,944,254
4.38%
-821,304
2.02%
03/29/2018
AXA Framlington UK Select Opportunities Fund
14,500,000
3.75%
-2,487,740
2.58%
03/15/2018
Government Pension Fund - Global (The)
8,393,506
2.17%
-1,780,747
0.01%
12/31/2017
St. James's Place Unit Trust - UK High Income
7,531,357
1.95%
0
2.4%
03/31/2018
Edinburgh Investment Trust Plc
5,712,684
1.48%
0
1.89%
03/31/2018
Vanguard Total International Stock Index Fund
5,541,140
1.43%
145,696
0.01%
07/31/2018
Perpetual Income & Growth Investment Trust Plc
3,505,724
0.91%
0
1.73%
03/31/2018
Schroder UTL - UK Mid 250 Fund
3,028,107
0.78%
0
1.41%
05/31/2018
| Address |
5 Fleet Place
London London & South East EC4M 7RD
United Kingdom
|
|
Employees
|
- |
| Website |
http://btgplc.com |
| Updated |
07/08/2019 |
| BTG Plc is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following business segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment provides therapies for cancer, sever emphysema, and vascular conditions such as severe blood clots and varicose veins. |
